Plan, track, and demonstrate
the impact of your work

Translational Science Benefits

The Translational Science Benefits Model is a framework designed to help public health and clinical scientists demonstrate the impact of their work in the real world. The model identifies 30 benefits of clinical and translational science in four domains: Clinical, Community, Economic, and Policy.

What is the TSBM?

gear icon

Translating for Impact Toolkit

Apply the TSBM Model to your own work

Want to learn more? Read our overview and FAQs.

Create Toolkit Account

Save your work, keep track, and share progress with your colleagues.

News & Events

Need to describe your research impact beyond publications? Try the Translational Science Benefits Model

Becker Medical Library (wustl.edu)

Post from Becker Blog at Bernard Becker Medical Library on using the TSBM to describe research impact.

The Translational Science Benefits Model: Moving beyond traditional measures of research impact

Recording of SciCom seminar presentation by Stephanie Andersen: The Translational Science Benefits Model: Moving beyond traditional measures of research impact…

TSBM & IRI partner to develop six impact case studies

In fall 2021, the Translational Science Benefits Model project team at the Center for Public Health Systems Science at the Brown School at…

The Tools in Use

Explore our case studies that demonstrate the TSBM in action.

Smiling group of people walking together outdoors stock photo

Assessing Community Belonging in Central OregonĀ 

By Oregon Clinical & Translational Research Institute (Oregon CTSA)

A closer look at belonging and mental wellbeing in priority populations

Collaboration Across Campuses: The NCCU Clinical Research Sciences Program

By Duke University Clinical & Translational Science

Creating an environment for producing a highly trained and diverse workforce in clinical research

New Option for Treatment of Uterine Fibroids: Engineering Smart Therapeutics

By Duke University Clinical & Translational Science

Developing and testing a minimally invasive treatment option for women with uterine fibroids